Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Allergic rhinitis: Disease characteristics and coping measures in Saudi Arabia.

Tytuł:
Allergic rhinitis: Disease characteristics and coping measures in Saudi Arabia.
Autorzy:
Almehizia AA; King Saud Bin Abdulaziz University for Health Science, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
AlEssa RK; King Saud Bin Abdulaziz University for Health Science, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Alwusaidi KM; Imam Saud bin Abdulaziz University, Riyadh, Saudi Arabia.
Alzamil KA; Imam Saud bin Abdulaziz University, Riyadh, Saudi Arabia.
AlJumah M; Alfarabi University, Riyadh, Saudi Arabia.
Aljohani S; King Saud Bin Abdulaziz University for Health Science, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Almutairi AF; King Saud Bin Abdulaziz University for Health Science, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Salam M; King Saud Bin Abdulaziz University for Health Science, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Źródło:
PloS one [PLoS One] 2019 Jun 26; Vol. 14 (6), pp. e0217182. Date of Electronic Publication: 2019 Jun 26 (Print Publication: 2019).
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: San Francisco, CA : Public Library of Science
MeSH Terms:
Rhinitis, Allergic/*epidemiology
Adult ; Cross-Sectional Studies ; Female ; Humans ; Male ; Rhinitis, Allergic/prevention & control ; Rhinitis, Allergic/therapy ; Saudi Arabia/epidemiology ; Severity of Illness Index
References:
Iran J Otorhinolaryngol. 2013 Spring;25(71):79-84. (PMID: 24303424)
J Allergy Clin Immunol. 2007 Aug;120(2):359-65. (PMID: 17531304)
J Allergy Clin Immunol. 2015 Jan;135(1):143-50. (PMID: 25085342)
Int Forum Allergy Rhinol. 2018 Oct;8(10):1098-1106. (PMID: 29979840)
Environ Res. 2017 May;155:134-140. (PMID: 28219016)
Pak J Med Sci. 2013 Apr;29(2):642-6. (PMID: 24353595)
J Med Econ. 2015;18(11):909-18. (PMID: 26481690)
Iran J Med Sci. 2019 Mar;44(2):87-98. (PMID: 30936595)
J Investig Allergol Clin Immunol. 2008;18(5):327-34. (PMID: 18973095)
World Allergy Organ J. 2013 Apr 04;6(1):7. (PMID: 23663517)
Iran J Med Sci. 2016 May;41(3 Suppl):S46. (PMID: 27840512)
Ann Saudi Med. 2017 Sep-Oct;37(5):357-361. (PMID: 28988249)
Proc Am Thorac Soc. 2011 Mar;8(1):106-14. (PMID: 21364228)
N Engl J Med. 2015 Jan 29;372(5):456-63. (PMID: 25629743)
Int Forum Allergy Rhinol. 2013 Jun;3(6):504-9. (PMID: 23307785)
Am J Rhinol Allergy. 2012 Nov-Dec;26 Suppl 1:S3-23. (PMID: 23232281)
J Epidemiol Glob Health. 2017 Mar;7(1):37-44. (PMID: 27362662)
Asia Pac Allergy. 2011 Oct;1(3):152-6. (PMID: 22053312)
Allergy. 2008 Apr;63 Suppl 86:8-160. (PMID: 18331513)
PLoS Med. 2014 Mar 11;11(3):e1001611. (PMID: 24618794)
Lancet. 2011 Dec 17;378(9809):2112-22. (PMID: 21783242)
J Allergy Clin Immunol. 2017 Oct;140(4):950-958. (PMID: 28602936)
Prim Care. 2008 Mar;35(1):1-10, v. (PMID: 18206714)
Allergy Asthma Proc. 2007 Jan-Feb;28(1):3-9. (PMID: 17390749)
Clin Exp Otorhinolaryngol. 2008 Dec;1(4):196-200. (PMID: 19434267)
Respir Med. 2015 Sep;109(9):1089-104. (PMID: 26073963)
Front Immunol. 2014 Mar 03;5:76. (PMID: 24624129)
World Allergy Organ J. 2014 Aug 01;7(1):19. (PMID: 25097721)
J Toxicol Environ Health A. 2006 Feb;69(3-4):229-35. (PMID: 16263693)
Treat Respir Med. 2005;4(6):439-46. (PMID: 16336028)
J Allergy Clin Immunol. 2016 May;137(5):1460-5. (PMID: 26883461)
Clin Dev Immunol. 2005 Jun;12(2):151-8. (PMID: 16050147)
Int Arch Allergy Immunol. 2012;158(4):397-404. (PMID: 22487690)
Allergy Asthma Clin Immunol. 2015 Dec 04;11:36. (PMID: 26640494)
Allergy Asthma Clin Immunol. 2018 Nov 21;14:77. (PMID: 30479630)
Ann Allergy Asthma Immunol. 2001 Mar;86(3):292-6. (PMID: 11289327)
J Investig Allergol Clin Immunol. 2013;23(3):145-51. (PMID: 23967752)
Ther Clin Risk Manag. 2005 Dec;1(4):265-71. (PMID: 18360569)
J Arthropod Borne Dis. 2017 May 27;11(2):309-314. (PMID: 29062855)
Allergy. 1983 Feb;38(2):85-92. (PMID: 6846741)
Entry Date(s):
Date Created: 20190627 Date Completed: 20200203 Latest Revision: 20200309
Update Code:
20240104
PubMed Central ID:
PMC6594581
DOI:
10.1371/journal.pone.0217182
PMID:
31242201
Czasopismo naukowe
Background: Despite allergic rhinitis (AR) being a highly prevalent disease, according to literature, it is often underdiagnosed or undertreated.
Aim: This study explored the disease characteristics of AR in the Saudi community and the non-conventional coping measures used to alleviate symptoms.
Methods: The study was a nationwide cross-sectional study, using a self-report electronic survey distributed via social media networks in 2018. The survey included an explanatory letter and consent. The sample size comprised 3,458 participants and 2,849 adults had at least one of the four signs of AR, i.e. watery-nose, sneezing, nasal obstruction, itchy nose, watery eyes, in the past year, not related to cold/flu. The outcomes of the study were the triggers, pattern, severity and the classification of AR (2016 ARIA guidelines) and coping measures. Descriptive statistics, univariate analytic statistics and binary logistic regression analyses were conducted. The P-value was considered statistically significant at <0.05.
Results: The leading reported trigger of AR was dust (74%, n = 2118), followed by pollen (17%, n = 477), mold (5%, n = 140) and fur (4%, n = 114). The prevalence of intermittent AR was (54%, n = 1,635), while that of persistent AR was (46%, n = 1,314). Almost one-third (34%, n = 959) complained of mild forms of AR, while others complained of moderate to severe forms (66%, n = 1890). The coping measures were mainly shower/humidification 368(12.9%) and herbal hot drinks 266(9.3%). Older participants (adj.OR = 1.3[1.1-1.5]) and overweight participants, (adj.OR = 1.2[1.1-1.4]) reported more persistent forms of rhinitis compared to their counter groups, (adj.P<0.001 and adj.P = 0.032) respectively. Female participants (adj.OR = 0.8[0.7-0.9]) had significantly milder forms of AR, in comparison to males, adj.P = 0.006.
Conclusion: This study presented the disease characteristics of self-reported AR and its associated factors in Saudi Arabia. Special attention should be paid to older age groups and overweight patients who reported persistent forms of AR. Males reported more severe and persistent forms of AR.
Competing Interests: The authors have declared that no competing interests exist.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies